Cancer marker test available in London
TORONTO – Biotech firm GeneNews Ltd. broadens access to its ColonSentry genomic technology – a test to determine risk for colorectal cancer – by providing it to three Gamma-Dynacare Medical Laboratories’ patient service centres in London, Ont. Click here for more information.
